News
-
Grande Portage Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
-
Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome
-
Orogen Royalties Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders
-
LQR House Announces Upcoming Marketing Partnerships With Saltwater Woody
-
Brenmiller Energy CEO Provides Update On Milestones Powering Progress
-
ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
-
naoo AG Launches New App Version with Major Performance Boost and Additional Features
-
INDUS adds U.S. fabrication and engineering expertise through strategic acquisition
-
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
-
Original-Research: Ernst Russ AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
-
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/05/2025
-
Déclaration du nombre d’actions et droits de vote au 31 mai 2025
-
Disclosure of Share Capital and Voting Rights as of May 31, 2025
-
Déclaration nombre d'actions et droits de vote - 04.06.2025
-
Disclosure of shares outstanding and voting rights - 04.06.2025